Analytical Data
-
Gene name
DCP2
- Application
-
Alternative Names
DCP2
-
Species
Human
-
Source
E. coli
-
Tag
Strep;His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8IU60-1
-
Expression Region
M95-P260
-
Protein Length
Partial
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DCP2 (Decapping Protein 2) is a pivotal enzyme involved in mRNA decay, playing a crucial role in the regulation of gene expression and maintaining cellular homeostasis. It is part of the decapping complex that catalyzes the removal of the 5' cap structure of mRNA, leading to its degradation by exonucleases. Dysregulation of DCP2 has been implicated in various diseases, including cancer and neurological disorders, highlighting its significance in cellular processes. Researchers have been focusing on recombinant DCP2 protein to better understand its structure-function relationships, enzymatic mechanisms, and interactions with other cellular components. The study of DCP2 not only provides insights into mRNA metabolism but also opens avenues for therapeutic interventions targeting diseases associated with aberrant mRNA decay pathways. Overall, the exploration of DCP2 as a recombinant protein is essential for deciphering its biological functions and potential roles in disease mechanisms.
